Skip to main content
Clinical Trials/EUCTR2014-000727-25-NL
EUCTR2014-000727-25-NL
Active, not recruiting
Phase 1

The effect of ARTISS on latissimus dorsi donor site seroma formation after breast reconstruction: a randomised controlled trial.

Isala Klinieken0 sitesStarted: March 28, 2017Last updated:
DrugsARTISS

Overview

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Isala Klinieken

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • All female patients older than 18 years, who will undergo a breast reconstruction with a LD flap will be included. All participating patients have to sign a written consent, before they can be included in our study.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 118
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Patients who are pregnant, have a pre\-operative on\-going infection, history of systemic anti\-coagulant use, known hypersensitivity to ARTISS or postoperative haemorrhage will be excluded.

Investigators

Sponsor
Isala Klinieken

Similar Trials